Mountain View, CA, United States of America

Francisco A Leon

This inventor holds 36 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Nanowire Technology. Top assignees: Intel Corporation, Nanosys, Inc., Applied Materials, Inc.. Active years: 1994-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francisco A Leon. Retrieved from https://idiyas.com/inventor/francisco-a-leon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 36 (Patent Applications = 8)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 3.2

ph-index = 15

Forward Citations = 518(Granted Patents)

Location History:

Mountain View, CA (US) (1994 - 1997)
Palo Alto, CA (US) (2000 - 2015)
Bethesda, MD (US) (2009 - 2024)

Company Filing History:

Applied Materials, Inc.

patents

4. 4 out of 5,300

Nippon Telegraph and Telephone Corporation

patents

5. 3 out of 3,746

Bristol-Myers Squibb Compnay

Sharp Kabushiki Kaisha Corporation

Applied Material, Inc.

patents

10. 1 out of 1

Benaroya Research Institure at Virginia Mason

14. 2 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2026

Loading Chart...

Areas of Expertise:

Type 1 Diabetes

Celiac Disease

Nanowire Alignment

Optical Detectors

EUV Lithography

Organic Electronics

Waveguide Detectors

Conductive Polymers

Phase Shift Masks

Thermal Budget

Self-Aligned Structures

Three-Dimensional Simulation

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12565529 - METHODS FOR TREATING TYPE 1 DIABETES (2026-03-03),

2. 12006366 - Methods and compositions for preventing type 1 diabetes (2024-06-11),

3. 11655294 - Methods and compositions for the treatment of celiac disease, non-celiac gluten sensitivity, and refractory celiac disease (2023-05-23),

4. 11434291 - Methods and compositions for preventing type 1 diabetes (2022-09-06),

5. 8999851 - Methods for formation of substrate elements (2015-04-07),

6. 8969531 - Anti-CD80 antibody (2015-03-03),

7. 8378082 - Anti-CD86 antibody (2013-02-19),

8. 8252164 - Methods for nanowire alignment and deposition (2012-08-28),

9. 8030161 - Gate electrode for a nonvolatile memory cell (2011-10-04),

10. 7968474 - Methods for nanowire alignment and deposition (2011-06-28),

11. 7871870 - Method of fabricating gate configurations for an improved contacts in nanowire based electronic devices (2011-01-18),

12. 7760980 - Ridge technique for fabricating an optical detector and an optical waveguide (2010-07-20),

13. 7701014 - Gating configurations and improved contacts in nanowire-based electronic devices (2010-04-20),

14. 7553371 - Porous substrates, articles, systems and compositions comprising nanofibers and methods of their use and production (2009-06-30),

15. 7528111 - Method of vaccinating subjects receiving immune modulating therapy (2009-05-05),

Title: Innovator Spotlight: Francisco A. Leon

Introduction

Francisco A. Leon, based in Mountain View, CA, is an esteemed inventor with an impressive portfolio of 35 patents. His contributions to the fields of immunology and inflammatory disorders highlight not only his innovative spirit but also his commitment to improving human health.

Latest Patents

Among his latest patents, Francisco has developed groundbreaking methods and compositions aimed at preventing type 1 diabetes. This method involves administering an anti-CD3 antibody to non-diabetic individuals at risk for the disease while monitoring specific T-cell markers for effective prevention or delay of clinical type 1 diabetes (T1D). Another significant patent focuses on the treatment of celiac disease and related disorders, providing new methods and pharmaceutical compositions that target inflammatory responses associated with celiac disease, non-celiac gluten sensitivity, and refractory celiac disease.

Career Highlights

Over the years, Francisco has made notable contributions while working with leading companies such as Intel Corporation and Nanosys, Inc. His deep understanding of biomedical applications has allowed him to innovate effectively within these prominent organizations.

Collaborations

Francisco is known for collaborating with esteemed colleagues, including Satoshi Tazawa and David P. Stumbo. These partnerships have fostered the development of novel treatments and solutions, significantly impacting the medical field.

Conclusion

Francisco A. Leon’s dedication to innovation through his patents demonstrates his remarkable ability to address critical health challenges. His work not only enhances our understanding of diseases like type 1 diabetes and celiac disease but also paves the way for future advancements in medical treatments, showcasing the vital role of inventors in shaping a healthier society.

Profile summary based on public USPTO records.